Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Antimicrobial Activity against E. coli ATCC 11775, S. maltophilia ATCC 13636 and S. enteritidis ATCC 13076

Linear, dimeric, tetrameric, and cyclic peptides derived from lactoferricin B-containing non-natural amino acids and the RWQWR motif were synthesized, purified, and characterized using RP-HPLC, MALDI-TOF mass spectrometry, and circular dichroism. The antibacterial activity of peptides against ATCC 1...

Full description

Saved in:
Bibliographic Details
Published inMolecules (Basel, Switzerland) Vol. 22; no. 3; p. 452
Main Authors Huertas Méndez, Nataly De Jesús, Vargas Casanova, Yerly, Gómez Chimbi, Anyelith Katherine, Hernández, Edith, Leal Castro, Aura Lucia, Melo Diaz, Javier Mauricio, Rivera Monroy, Zuly Jenny, García Castañeda, Javier Eduardo
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 12.03.2017
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Linear, dimeric, tetrameric, and cyclic peptides derived from lactoferricin B-containing non-natural amino acids and the RWQWR motif were synthesized, purified, and characterized using RP-HPLC, MALDI-TOF mass spectrometry, and circular dichroism. The antibacterial activity of peptides against ATCC 11775, ATCC 13636, and ATCC 13076 was evaluated. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined. The synthetic bovine lactoferricin exhibited antibacterial activity against ATCC 11775 and ATCC 13076. The dimeric peptide (RRWQWR)₂K-Ahx exhibited the highest antibacterial activity against the tested bacterial strain. The monomeric, cyclic, tetrameric, and palindromic peptides containing the RWQWR motif exhibited high and specific activity against ATCC 11775. The results suggest that short peptides derived from lactoferricin B could be considered as potential candidates for the development of antibacterial agents against infections caused by .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
ISSN:1420-3049
1420-3049
DOI:10.3390/molecules22030452